However, in basal‐like breast cancer, mutations in MAP3K1 or MAP2K4 are notably absent (Cancer Genome Atlas Network, 2012), suggesting that they may not provide similar increase in cellular fitness to what is observed in luminal breast cancer cells. This evidence concerns the gene MAP2K4 and breast carcinoma.